ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
A side-by-side editorial comparison of DoseFinding and Grafana Mimir — release velocity, themes, recent moves, and the top alternatives to consider.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months
The visible cadence is an automated weekly Helm chart release opened by a bot with a two-line body, now at 6.3.0-weekly.408. The only substantive entry in the window is the 3.2.0 release candidate from early August, which carried query engine work and native histogram support.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
The visible cadence is an automated weekly Helm chart release opened by a bot with a two-line body, now at 6.3.0-weekly.408. The only substantive entry in the window is the 3.2.0 release candidate from early August, which carried query engine work and native histogram support.
Packaging and the engine move on separate clocks: the chart ships weekly regardless of whether anything changed underneath, while Mimir itself cuts a minor roughly monthly. The weekly stream tells you nothing about direction and will keep dominating the feed by volume.
The chart line moving from 6.2.0-weekly to 6.3.0-weekly points at a 6.3.0 chart release carrying Mimir 3.2 once the candidate goes final.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or Grafana Mimir.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
See all DoseFinding alternatives → · See all Grafana Mimir alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Grafana Mimir is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Grafana Mimir is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
Top Grafana Mimir alternatives in Analytics are ranked by recent ship velocity. Browse the "Grafana Mimir alternatives" section above for the current picks, or visit /alternatives/grafana-mimir for the full list with editorial commentary on each.